Editorial Policies

Focus and Scope

IJNSP is a scientific journal to develop knowledge in the field of Nursing, IJNSP provides a platform for the publication of scientific research in the all areas of nursing such as:

  • Advanced Practice Nursing
  • Community Health Nursing
  • Emergency and Trauma Nursing
  • Education in Nursing
  • Family Nursing
  • Fundamentals of Nursing
  • Geriatric Nursing
  • Management in Nursing
  • Maternity Nursing
  • Mental Health Nursing
  • Medical-surgical Nursing
  • Oncology Nursing
  • Pediatric Nursing
  • Women's Health 


 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Plagiarism Policy

The Indonesian Journal of Nursing Sciences and Practice (IJNSP) board recognized that plagiarism is not acceptable and therefore establishes the following policy stating specific actions (penalties) when plagiarism is identified in an article that is submitted for publication in IJNSP. Definition:

Plagiarism involves the "use or close imitation of the language and thoughts of another author and the representation of them as one's own original work."

Policy:

Papers must be original, unpublished, and not pending publication elsewhere. Any material taken verbatim from another source needs to be clearly identified as different from the present original text by (1) indentation, (2) use of quotation marks, and (3) identification of the source.

Any text of an amount exceeding fair use standards (herein defined as more than two or three sentences or the equivalent thereof) or any graphic material reproduced from another source requires permission from the copyright holder and, if feasible, the original author(s) and also requires identification of the source; e.g., previous publication.

When plagiarism is identified, the Editor in Chief responsible for the review of this paper and will agree on measures according to the extent of plagiarism detected in the paper in agreement with the following guidelines:

Level of Plagiaris

1. Minor : A short section of another article is plagiarized without any significant data or idea taken from the other paper

Action : A warning is given to the authors and a request to change the text and properly cite the original article is made

2. Intermediate: A significant portion of a paper is plagiarized without proper citation to the original paper

Action : The submitted article is rejected and the authors are forbidden to submit further articles for one year

3. Severe : A significant portion of a paper is plagiarized that involves reproducing original results or ideas presented in another publication

Action : The paper is rejected and the authors are forbidden to submit further articles for five years.

 

It is understood that all authors are responsible for the content of their submitted paper as they all sign the IJNSP Copyright Transfer Form. If a penalty is imposed for plagiarism, all authors will be subject to the same penalty.

If a second case of plagiarism by the same author(s) is identified, a decision on the measures to be enforced will be made by the Editorial board (Editor-in-Chief, and Editorial members) with the Chair of the Editor in Chief. The author(s) might be forbidden to submit further articles forever.

This policy applies also to material reproduced from another publication by the same author(s). If an author uses text or figures that have previously been published, the corresponding paragraphs or figures should be identified and the previous publication referenced. It is understood that in case of a review paper or a paper of a tutorial nature much of the material was previously published.

The author should identify the source of the previously published material and obtain permission from the original author and the publisher. If an author submits a manuscript to IJNSP with significant overlap with a manuscript submitted to another journal simultaneously, and this overlap is discovered during the review process or after the publications of both papers, the editor of the other journal is notified and the case is treated as a severe plagiarism case. Significant overlap means use of identical or almost identical figures and identical or slightly modified text for one half or more of the paper. For self plagiarism of less than one half of the paper but more than one tenth of the paper, the case shall be treated as intermediate plagiarism. If self plagiarism is confined to the methods section, the case shall be considered as minor plagiarism.

 If an author uses some of his previously published material to clarify the presentation of new results, the previously published material shall be identified and the difference to the present publication shall be mentioned. Permission to republish must be obtained from the copyright holder. In the case of a manuscript that was originally published in conference proceedings and then is submitted for publication in IJNSP either in identical or in expanded form, the authors must identify the name of the conference proceedings and the date of the publication and obtain permission to republish from the copyright holder. The editor may decide not to accept this paper for publication.

However, an author shall be permitted to use material from an unpublished presentation, including visual displays, in a subsequent journal publication. In the case of a publication being submitted that was originally published in another language, the title, date and journal of the original publication must be identified by the authors, and the copyright must be obtained. The editor may accept such a translated publication to bring it to the attention of a wider audience. The editor may select a specific paper that had been published (e.g. a “historic” paper) for republication in order to provide a better perspective of a series of papers published in one issue of IJNSP. This republication shall be clearly identified as such and the date and journal of the original publication shall be given, and the permission of the author(s) and the publisher shall be obtained.

The IJNSP layout editor for the Journal is responsible for maintaining the list of authors subjected to penalties and will check that no authors of a submitted paper are on this list. If a banned author is identified, the layout editor will inform the Editor-in-Chief who will take appropriate measures. This policy will be posted on the web site with the instructions for submitting a manuscript, and a copy will be sent to the authors with the confirmation email upon initial receipt of their original manuscript. A sentence shall be added to the copyright transfer form to indicate that the author(s) have read the Plagiarism Policy.

 

Publication Frequency

Periodic journal published every semester, in January and July.

 

Open Access Statement

IJNSP publishes fully open access journals, which means that all articles are available on the internet to all users immediately upon publication. Non-commercial use and distribution in any medium are permitted, provided the author and the journal are properly credited.

Benefits of open access for authors include:

  • Free access for all users worldwide
  • Authors retain copyright to their work
  • Increased visibility and readership
  • Rapid publication
  • No spatial constraints

 

Copyright and License Statement

Authors who publish with this journal agree to the following terms:

 

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

 

License Grant. Subject to the terms and conditions of this License, Licensor hereby grants You a worldwide, royalty-free, non-exclusive, perpetual (for the duration of the applicable copyright) license to exercise the rights in the Work as stated below:

  1. To Reproduce the Work, to incorporate the Work into one or more Collections, and to Reproduce the Work as incorporated in the Collections;
  2. To create and Reproduce Adaptations provided that any such Adaptation, including any translation in any medium, takes reasonable steps to clearly label, demarcate or otherwise identify that changes were made to the original Work. For example, a translation could be marked "The original work was translated from English to Spanish," or a modification could indicate "The original work has been modified.";
  3. To Distribute and Publicly Perform the Work including as incorporated in Collections; and,
  4. To Distribute and Publicly Perform Adaptations.
  5. For the avoidance of doubt:i. Non-waivable Compulsory License Schemes. In those jurisdictions in which the right to collect royalties through any statutory or compulsory licensing scheme cannot be waived, the Licensor reserves the exclusive right to collect such royalties for any exercise by You of the rights granted under this License;ii. Waivable Compulsory License Schemes. In those jurisdictions in which the right to collect royalties through any statutory or compulsory licensing scheme can be waived, the Licensor waives the exclusive right to collect such royalties for any exercise by You of the rights granted under this License; and,iii. Voluntary License Schemes. The Licensor waives the right to collect royalties, whether individually or, in the event that the Licensor is a member of a collecting society that administers voluntary licensing schemes, via that society, from any exercise by You of the rights granted under this License.

The above rights may be exercised in all media and formats whether now known or hereafter devised. The above rights include the right to make such modifications as are technically necessary to exercise the rights in other media and formats. Subject to Section 8(f), all rights not expressly granted by Licensor are hereby reserved.

Restrictions. The license granted in Section 3 above is expressly made subject to and limited by the following restrictions:

  1. You may Distribute or Publicly Perform the Work only under the terms of this License. You must include a copy of, or the Uniform Resource Identifier (URI) for, this License with every copy of the Work You Distribute or Publicly Perform. You may not offer or impose any terms on the Work that restrict the terms of this License or the ability of the recipient of the Work to exercise the rights granted to that recipient under the terms of the License. You may not sublicense the Work. You must keep intact all notices that refer to this License and to the disclaimer of warranties with every copy of the Work You Distribute or Publicly Perform. When You Distribute or Publicly Perform the Work, You may not impose any effective technological measures on the Work that restrict the ability of a recipient of the Work from You to exercise the rights granted to that recipient under the terms of the License. This Section 4(a) applies to the Work as incorporated in a Collection, but this does not require the Collection apart from the Work itself to be made subject to the terms of this License. If You create a Collection, upon notice from any Licensor You must, to the extent practicable, remove from the Collection any credit as required by Section 4(b), as requested. If You create an Adaptation, upon notice from any Licensor You must, to the extent practicable, remove from the Adaptation any credit as required by Section 4(b), as requested.
  2. If You Distribute, or Publicly Perform the Work or any Adaptations or Collections, You must, unless a request has been made pursuant to Section 4(a), keep intact all copyright notices for the Work and provide, reasonable to the medium or means You are utilizing: (i) the name of the Original Author (or pseudonym, if applicable) if supplied, and/or if the Original Author and/or Licensor designate another party or parties (e.g., a sponsor institute, publishing entity, journal) for attribution ("Attribution Parties") in Licensor's copyright notice, terms of service or by other reasonable means, the name of such party or parties; (ii) the title of the Work if supplied; (iii) to the extent reasonably practicable, the URI, if any, that Licensor specifies to be associated with the Work, unless such URI does not refer to the copyright notice or licensing information for the Work; and (iv) , consistent with Section 3(b), in the case of an Adaptation, a credit identifying the use of the Work in the Adaptation (e.g., "French translation of the Work by Original Author," or "Screenplay based on original Work by Original Author"). The credit required by this Section 4 (b) may be implemented in any reasonable manner; provided, however, that in the case of a Adaptation or Collection, at a minimum such credit will appear, if a credit for all contributing authors of the Adaptation or Collection appears, then as part of these credits and in a manner at least as prominent as the credits for the other contributing authors. For the avoidance of doubt, You may only use the credit required by this Section for the purpose of attribution in the manner set out above and, by exercising Your rights under this License, You may not implicitly or explicitly assert or imply any connection with, sponsorship or endorsement by the Original Author, Licensor and/or Attribution Parties, as appropriate, of You or Your use of the Work, without the separate, express prior written permission of the Original Author, Licensor and/or Attribution Parties.
  3. Except as otherwise agreed in writing by the Licensor or as may be otherwise permitted by applicable law, if You Reproduce, Distribute or Publicly Perform the Work either by itself or as part of any Adaptations or Collections, You must not distort, mutilate, modify or take other derogatory action in relation to the Work which would be prejudicial to the Original Author's honor or reputation. Licensor agrees that in those jurisdictions (e.g. Japan), in which any exercise of the right granted in Section 3(b) of this License (the right to make Adaptations) would be deemed to be a distortion, mutilation, modification or other derogatory action prejudicial to the Original Author's honor and reputation, the Licensor will waive or not assert, as appropriate, this Section, to the fullest extent permitted by the applicable national law, to enable You to reasonably exercise Your right under Section 3(b) of this License (right to make Adaptations) but not otherwise.

Representations, Warranties and Disclaimer

UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING, LICENSOR OFFERS THE WORK AS-IS AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTIBILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT DISCOVERABLE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO SUCH EXCLUSION MAY NOT APPLY TO YOU.

Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN NO EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES ARISING OUT OF THIS LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

Termination

  1. This License and the rights granted hereunder will terminate automatically upon any breach by You of the terms of this License. Individuals or entities who have received Adaptations or Collections from You under this License, however, will not have their licenses terminated provided such individuals or entities remain in full compliance with those licenses. Sections 1, 2, 5, 6, 7, and 8 will survive any termination of this License.
  2. Subject to the above terms and conditions, the license granted here is perpetual (for the duration of the applicable copyright in the Work). Notwithstanding the above, Licensor reserves the right to release the Work under different license terms or to stop distributing the Work at any time; provided, however that any such election will not serve to withdraw this License (or any other license that has been, or is required to be, granted under the terms of this License), and this License will continue in full force and effect unless terminated as stated above.

Miscellaneous

  1. Each time You Distribute or Publicly Perform the Work or a Collection, the Licensor offers to the recipient a license to the Work on the same terms and conditions as the license granted to You under this License.
  2. Each time You Distribute or Publicly Perform an Adaptation, Licensor offers to the recipient a license to the original Work on the same terms and conditions as the license granted to You under this License.
  3. If any provision of this License is invalid or unenforceable under applicable law, it shall not affect the validity or enforceability of the remainder of the terms of this License, and without further action by the parties to this agreement, such provision shall be reformed to the minimum extent necessary to make such provision valid and enforceable.
  4. No term or provision of this License shall be deemed waived and no breach consented to unless such waiver or consent shall be in writing and signed by the party to be charged with such waiver or consent.
  5. This License constitutes the entire agreement between the parties with respect to the Work licensed here. There are no understandings, agreements or representations with respect to the Work not specified here. Licensor shall not be bound by any additional provisions that may appear in any communication from You. This License may not be modified without the mutual written agreement of the Licensor and You.
  6. The rights granted under, and the subject matter referenced, in this License were drafted utilizing the terminology of the Berne Convention for the Protection of Literary and Artistic Works (as amended on September 28, 1979), the Rome Convention of 1961, the WIPO Copyright Treaty of 1996, the WIPO Performances and Phonograms Treaty of 1996 and the Universal Copyright Convention (as revised on July 24, 1971). These rights and subject matter take effect in the relevant jurisdiction in which the License terms are sought to be enforced according to the corresponding provisions of the implementation of those treaty provisions in the applicable national law. If the standard suite of rights granted under applicable copyright law includes additional rights not granted under this License, such additional rights are deemed to be included in the License; this License is not intended to restrict the license of any rights under applicable law.

 

Article Processing Charge (APC)

This journal charges the following author fees.

Article Submission: 0.00 (IDR)
Authors are required to pay an Article Submission Fee as part of the submission process to contribute to review costs.

 

Article Publication: 0.00 (IDR)
If this paper is accepted for publication, you will be asked to pay an Article Publication Fee to cover publications costs.

 

If you do not have funds to pay such fees, you will have an opportunity to waive each fee. We do not want fees to prevent the publication of worthy work.

 

Publication Ethics

Human Participants

IJNSP policy is to ensure that all articles published by IJNSP report on work that is morally acceptable, and expects authors to follow the World Medical Association’s Declaration of Helsinki. To achieve this, we aim to appraise the ethical aspects of any submitted work that involves human participants, whatever descriptive label is given to that work including research, audit, and sometimes debate.

Statement of Ethics Approval

We require every research article submitted to include a statement that the study obtained ethics approval (or a statement that it was not required and why), including the name of the ethics committee(s) or institutional review board(s), the number/ID of the approval(s), and a statement that participants gave informed consent before taking part.

In addition we welcome detailed explanations of how investigators and authors have considered and justified the ethical and moral basis of their work. If such detail does not easily fit into the manuscript please provide it in the covering letter or upload it as a supplemental file when submitting the article. We will also be pleased to see copies of explanatory information given to participants. Even if we do not include such detailed information in a final published version, we may make it available to peer reviewers and editorial committees. We already ask peer reviewers to consider and comment on the ethics of submitted work.

Appraisal of Ethical Issues

Editorial appraisal of ethical issues goes beyond simply deciding whether participants in a study gave informed consent although this is, of course, one very important issue to consider. Editors should judge whether the overall design and conduct of each piece of work is morally justifiable, as summed up by the following questions:

  • How much does this deviate from current normal (accepted, local) clinical practice?
  • What is the (additional) burden imposed on the patients (or others)?
  • What (additional) risks are posed to the patients (or others)?
  • What benefit might accrue to the patients (or others)?
  • What are the potential benefits to society (future patients)?

Even when a study has been approved by a research ethics committee or institutional review board, editors may be worried about the ethics of the work. Editors may then ask authors for more detailed information such as:

  • How they justified the ethical and moral basis of the work
  • To provide the contact details of the research ethics committee that reviewed the work, so that the journal can request further information and justification from that committee
  • To explain what ethical issues they considered and how they justified their work, for studies that have not been reviewed by research ethics committees or institutional review boards

Editors may ask other editorial colleagues to evaluate the ethical aspects of an article, the authors’ comments, and the response of the relevant research ethics committee to the journal’s queries about ethics approval. This consultation may be informal, between the journal’s editors, or more formal, through seeking the advice of the Committee on Publication Ethics (COPE). Problems referred to COPE will be considered as anonymised summaries of the relevant articles, written by the editors concerned.

What happens when the journal considers a study to be unethical?

We believe that editors have a duty to take on issues of unethical audit or research, not to seek punishment for the authors, but to prevent unethical practice and to protect patients.

If the Editor, with or without the advice of its ethics committee and/or COPE, considers the work in a submitted article to be ethically unsound the editor may seek further advice or recommend investigation or action. The fact that the article would have been rejected anyway for other scientific or editorial reasons would not prevent the editor from taking such further action on serious ethics problems.

In the first instance the editor would usually contact the head of the department where the work was done to explain their concerns and recommend a local investigation. Secondly, the editor might write to the professional registration body of the paper’s guarantor or principal investigator.

Exceptional circumstances

In rare instances the journal might publish an article despite ethics problems in the work it reported. The usual reason would be that work done in one setting might not reach the ethical standard of work done in another setting, because of differing local resources and standards for health care and research. In deciding to publish such an article, we would consider carefully the context of the study and aim to balance the overall benefit to society against the possible harm to the research participants.

Animal Participants

All material published in IJNSP which reports experiments performed using animals must adhere to high ethical standards concerning animal welfare.

Manuscripts will be considered for publication only if the work described:

  • Follows international, national and institutional guidelines for the humane treatment of animals and complies with relevant legislation;
  • Has been approved by the ethics review committee at the institution or practice at which the studies were conducted (where such a committee exists);
  • For studies involving non-human primates, demonstrates that the standards meet those of the NC3Rs primates guidelines;
  • For studies using client-owned animals, demonstrates a high standard (best practice) of veterinary care and involves informed client consent.

Before a manuscript can be accepted, authors must:

  • Confirm that legal and ethical requirements have been met with regards to the humane treatment of animals described in the study;
  • Specify in the Materials or Methods section the ethical review committee approval process and the international, national, and/or institutional guidelines followed.

Editors retain the right to reject manuscripts on the basis of ethical or animal welfare concerns. Papers may be rejected on ethical grounds if the study involves unnecessary pain, distress, suffering or lasting harm to animals, or if the severity of the experimental procedure does not appear to be justified by the value of the work presented. We ask that the work would be likely to gain approval in Europe under the European Directive 2010/63/EU (on the protection of animals used for scientific purposes).

See ‘What happens when the journal considers a study to be unethical?’ above for an outline of how ethical concerns will be dealt with. Manuscripts describing animal research must include a justification for the use of animals, and for the particular species used. They should also provide details of animal welfare, including information about housing, feeding and environmental enrichment, a description of steps taken to minimise suffering, humane endpoints and method of euthanasia. If the study has any implication for the 3Rs (replacement, reduction and refinement), these should be discussed in enough detail so that readers can implement the 3Rs in similar experiments.

VulnerableParticipants

IJNSP places a particular emphasis on research involving vulnerable participants. In the Declaration of Helsinki, the World Medical Association defines vulnerable groups and individuals as those who may have an increased likelihood of experiencing harm or injustice. Specifically, the Declaration identifies vulnerability as arising from a reduced ability to provide informed consent. It states, "Some research populations are particularly vulnerable and require special protection. These include individuals who cannot provide or refuse consent for themselves...," as well as those "who may be susceptible to coercion or undue influence."

According to the guidelines provided by the US Department of Health and Human Services regarding the Protection of Human Subjects, vulnerable groups specifically encompass children, prisoners, pregnant women, fetuses, individuals with mental disabilities, and economically and educationally disadvantaged individuals. Consequently, authors submitting manuscripts to IJNSP that involve vulnerable groups must provide a detailed explanation of the ethical process, informed consent procedures, and the legal guardian authorized to grant consent.

Categories of Vulnerability

The categoies of vulnerability based on National Bioethics Advisory Committee:

Cognitive or communicative vulnerability

Cognitive or communicative vulnerability occurs when any participant is unable to process, understand, appreciate, and reason through the consent documentation and/or explanations either by mental limitation or language limitation. There are various degrees as to how this may occur. For example, a participant may not be able to read a consent form because of illiteracy, low reading comprehension skills, and/or not speaking the language in which the form is written. If you are targeting a population where this is likely to occur, you need to provide a consent procedure that will accommodate the needs of your participants either by translating the document, writing it in lay language, or discussing the consent. In some cases, you may not be targeting this population, but the issue may arise during a consent session. Do your best to make sure that the participant understands what he or she is consenting to before enrolling them in the study. If you are likely to work with participants where capacity to consent is an issue, it may be necessary for you to include a procedure to assess the participant's capacity to consent. In the case where a participant may not be able to process the full meaning of consent (such as a young child) or is limited by mental defect or disorder, it will be necessary that you obtain consent from a surrogate who is legally responsible for the individual. Although the person may not be able to give full consent, it is still important to involve the person in the consent procedure as to their capability. 

Institutional vulnerability

Institutional vulnerability occurs when individuals are subject to a formal authority and whose consent may be coerced either directly or indirectly. Examples include prisoners, student/professor relationships, and/or employee/employer relationships. The role of the formal authority in the study will determine the level of perceived or real coercion in the study (i.e. professor studying his students). The solution to this issue is often in the manner in which data are collected and consent is obtained. Using a third party to do so often eliminates any conflicts of interest. However, in the case of prisoners, specific rules are in place regarding their use.

Deferential vulnerability

Deferential vulnerability occurs when individuals informally subordinate to an authority figure. For example, abuse victims, doctor/patient relationships, and/or husband/wife relationships are all situations where one party may feel obligated to follow the advice of another. These situations require a sensitive recruitment and consent plan where participants have the opportunity to consent voluntarily.

Medical vulnerability

Medical vulnerability occurs when individuals' medical state may cloud their ability to make a decision regarding study participation. The patient may see the research study as a miracle cure to their disease instead of a procedure that has no guarantee for results. Often presenting the study in an environment where the participant is able to understand the full meaning of the study will help to alleviate any misunderstanding.

Economic vulnerability

Economic vulnerability occurs when individuals' economic situation may make them vulnerable to the prospect of free medical care and/or the payments issued for participating in the study. It is important that the payment offered will not encourage an individual to put themselves at a greater risk than they would otherwise.

Social vulnerability

Social vulnerability occurs when participants are at risk for discrimination based on race, gender, ethnicity, and age. Researchers may not offer the full explanation in the consent because they feel a participant is not able to comprehend it because of that person’s race, etc. The participant may also be prone to feel discriminated against as well and may not participate as a result of this predisposition. 

Legal vulnerability

Legal vulnerability occurs when participants do not have the legal right to consent or who may be concerned that their consent could put them at risk for legal repercussions. For those who are unable to legally consent, it is important that you obtain consent from a legal representative and in most cases obtain assent from the individual. For those that are concerned about having their legal status compromised by the study, you should take steps to legally protect participants. For example, obtaining a Certificate of Confidentiality for U.S. citizens can protect confidentiality. For some, alternative consent methods may appropriate, such as oral consent.

Study vulnerability

Study vulnerability occurs when participants are made vulnerable by the study’s design. Generally this category refers to participants who are deceived during the study and/or the nature of the study is not revealed to the participant. This can be alleviated by providing full consent and disclosure after the study is completed or whenever a participant withdraws from the study.

 

Abstract and Indexing



Powered by Puskom-UMJ